Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196): Notice of 2026 First Class Meeting of H Shareholders

Bulletin Express

Feb 04

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) announced that a 2026 first class meeting of H shareholders is scheduled on 27 February 2026 at Sky Fortune Boutique Hotel Shanghai. This meeting will follow the conclusion of the company’s 2026 first extraordinary general meeting and 2026 first class meeting of A shareholders.

The key agenda item is a special resolution regarding the provision of assured entitlements to H shareholders in connection with the proposed spin-off of Fosun Adgenvax (a subsidiary of the company) for listing on the Main Board of the Hong Kong Stock Exchange. According to the announcement, H shareholders intending to attend must lodge their transfer documents by 23 February 2026, with the register for H shares scheduled to close from 24 February to 27 February 2026. The company notes that returning a proxy form does not preclude shareholders from attending and voting in person.

The announcement also outlines procedural information, including the lodging of proxies with the company’s Hong Kong share registrar. Shareholders who attend the meeting in person or by proxy will bear their own travel and accommodation expenses. The notice further clarifies that it is dispatched only to holders of H shares of the company.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1100323896"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1100323896\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1100323896?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-04 19:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100323896","market":"hk","top_or_hot":-1,"title":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196): Notice of 2026 First Class Meeting of H Shareholders","media":"Bulletin Express","content":"<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) announced that a 2026 first class meeting of H shareholders is scheduled on 27 February 2026 at Sky Fortune Boutique Hotel Shanghai. This meeting will follow the conclusion of the company’s 2026 first extraordinary general meeting and 2026 first class meeting of A shareholders.</p>\n<p>The key agenda item is a special resolution regarding the provision of assured entitlements to H shareholders in connection with the proposed spin-off of Fosun Adgenvax (a subsidiary of the company) for listing on the Main Board of the Hong Kong Stock Exchange. According to the announcement, H shareholders intending to attend must lodge their transfer documents by 23 February 2026, with the register for H shares scheduled to close from 24 February to 27 February 2026. The company notes that returning a proxy form does not preclude shareholders from attending and voting in person.</p>\n<p>The announcement also outlines procedural information, including the lodging of proxies with the company’s Hong Kong share registrar. Shareholders who attend the meeting in person or by proxy will bear their own travel and accommodation expenses. The notice further clarifies that it is dispatched only to holders of H shares of the company.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196): Notice of 2026 First Class Meeting of H Shareholders</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196): Notice of 2026 First Class Meeting of H Shareholders\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-04 19:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) announced that a 2026 first class meeting of H shareholders is scheduled on 27 February 2026 at Sky Fortune Boutique Hotel Shanghai. This meeting will follow the conclusion of the company’s 2026 first extraordinary general meeting and 2026 first class meeting of A shareholders.</p>\n<p>The key agenda item is a special resolution regarding the provision of assured entitlements to H shareholders in connection with the proposed spin-off of Fosun Adgenvax (a subsidiary of the company) for listing on the Main Board of the Hong Kong Stock Exchange. According to the announcement, H shareholders intending to attend must lodge their transfer documents by 23 February 2026, with the register for H shares scheduled to close from 24 February to 27 February 2026. The company notes that returning a proxy form does not preclude shareholders from attending and voting in person.</p>\n<p>The announcement also outlines procedural information, including the lodging of proxies with the company’s Hong Kong share registrar. Shareholders who attend the meeting in person or by proxy will bear their own travel and accommodation expenses. The notice further clarifies that it is dispatched only to holders of H shares of the company.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"复星医药","start_time":0,"source_url":"","article_id":"1100323896","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100323896","pubTimestamp":1770204272,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) announced that a 2026 first class meeting of H shareholders is scheduled on 27 February 2026 at Sky Fortune Boutique Hotel Shanghai. This...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02196":"复星医药"},"translate_title":"上海复星医药（集团）股份有限公司（02196）：2026年第一次H股类别股东大会通知","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02196":1},"content_text":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) announced that a 2026 first class meeting of H shareholders is scheduled on 27 February 2026 at Sky Fortune Boutique Hotel Shanghai. This meeting will follow the conclusion of the company’s 2026 first extraordinary general meeting and 2026 first class meeting of A shareholders.\nThe key agenda item is a special resolution regarding the provision of assured entitlements to H shareholders in connection with the proposed spin-off of Fosun Adgenvax (a subsidiary of the company) for listing on the Main Board of the Hong Kong Stock Exchange. According to the announcement, H shareholders intending to attend must lodge their transfer documents by 23 February 2026, with the register for H shares scheduled to close from 24 February to 27 February 2026. The company notes that returning a proxy form does not preclude shareholders from attending and voting in person.\nThe announcement also outlines procedural information, including the lodging of proxies with the company’s Hong Kong share registrar. Shareholders who attend the meeting in person or by proxy will bear their own travel and accommodation expenses. The notice further clarifies that it is dispatched only to holders of H shares of the company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}